W. Gerhard, K. Mozdzanowska, and D. Zharikova, Prospects for Universal Influenza Virus Vaccine, Emerging Infectious Diseases, vol.12, issue.4, pp.569-574, 2006.
DOI : 10.3201/eid1204.051020

S. M. Ebrahimi, K. Aghaiypour, and H. Nili, Sequence analysis of M2 gene of avian influenza virus strain (A/chicken (H9N2)) as an oil vaccine seed, Iran. J. Biotechnol, vol.101, issue.6, pp.98-229, 2008.

S. L. Zebedee and R. A. Lamb, Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions, J. Virol, pp.62-2762, 1988.

J. J. Treanor, E. L. Tierney, S. L. Zebedee, R. A. Lamb, and B. R. Murphy, Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice, J. Virol, pp.64-1375, 1990.

V. A. Slepushkin, J. M. Katz, R. A. Black, W. C. Gamble, P. A. Rota et al., Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein, Vaccine, vol.13, issue.15, pp.1399-1402, 1995.
DOI : 10.1016/0264-410X(95)92777-Y

. Fig, Cell?ELISA for the expressed M2 protein on the surface of infected MDCK cells Cells infected by influenza A/chickenH9N2) isolate within the wells of a 96-well plate were incubated with the pooled antisera from immunized rabbits at 6 h post-infection. After further treatment with HRP-conjugated goat anti-rabbit IgG and TMB substrate, the obtained signals in accordance to the serially diluted antisera (prepared on days 13 and 34 after first immunization)

S. Neirynck, T. Deroo, X. Saelens, P. Vanlandschoot, W. M. Jou et al., A universal influenza A vaccine based on the extracellular domain of the M2 protein, Nat. Med, vol.5, pp.1157-1163, 1999.

S. M. Tompkins, Z. S. Zhao, C. Y. Lo, J. A. Misplon, T. Liu et al., Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1, Emerging Infectious Diseases, vol.13, issue.3, pp.13-426, 2007.
DOI : 10.3201/eid1303.061125
URL : http://doi.org/10.3201/eid1303.061125

W. A. Ernst, H. J. Kim, T. M. Tumpey, A. D. Jansen, W. Tai et al., Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines, Vaccine, vol.24, issue.24, pp.5158-5168, 2006.
DOI : 10.1016/j.vaccine.2006.04.008

A. Jegerlehner, N. Schmitz, T. Storni, and M. F. Bachmann, Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity, The Journal of Immunology, vol.172, issue.9, pp.172-5598, 2004.
DOI : 10.4049/jimmunol.172.9.5598

J. Fan, X. Liang, M. S. Horton, H. C. Perry, M. P. Citron et al., Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys, Vaccine, vol.22, issue.23-24, pp.2993-3003, 2004.
DOI : 10.1016/j.vaccine.2004.02.021

C. F. Hung, W. F. Cheng, C. Y. Chai, K. F. Hsu, L. He et al., Improving Vaccine Potency Through Intercellular Spreading and Enhanced MHC Class I Presentation of Antigen, The Journal of Immunology, vol.166, issue.9, pp.166-5733, 2001.
DOI : 10.4049/jimmunol.166.9.5733

M. G. Cusi, C. Terrosi, G. G. Savellini, G. D. Genova, R. Zurbriggen et al., Efficient delivery of DNA to dendritic cells mediated by influenza virosomes, Vaccine, vol.22, issue.5-6, pp.735-739, 2004.
DOI : 10.1016/j.vaccine.2003.08.024

S. A. Calarota and D. B. Weiner, Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants, Immunological Reviews, vol.103, issue.4, pp.199-84, 2004.
DOI : 10.1038/79470

K. R. Qazia, M. Wikmanb, N. Vasconcelos, K. Berzins, S. Stahl et al., Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene, Vaccine, vol.23, issue.9, pp.1114-1125, 2005.
DOI : 10.1016/j.vaccine.2004.08.033

C. H. Chen, T. L. Wang, C. F. Hung, Y. Yang, R. A. Young et al., Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene, Cancer Res, pp.60-1035, 2000.

Y. Wang, C. G. Kelly, M. Singh, E. G. Mcgowan, A. S. Carrara et al., Stimulation of Th1-Polarizing Cytokines, C-C Chemokines, Maturation of Dendritic Cells, and Adjuvant Function by the Peptide Binding Fragment of Heat Shock Protein 70, The Journal of Immunology, vol.169, issue.5, pp.169-2422, 2002.
DOI : 10.4049/jimmunol.169.5.2422

]. X. Li, X. Yang, L. Li, H. Liu, and J. Liu, A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine, Vaccine, vol.24, issue.16, pp.3321-3331, 2006.
DOI : 10.1016/j.vaccine.2006.01.012

S. M. Ebrahimi, M. Tebianian, K. Aghaiypour, H. Nili, and A. Mirjalili, Prokaryotic expression and characterization of avian influenza A virus M2 gene as a candidate for universal recombinant vaccine against influenza A subtypes; specially H5N1 and H9N2, Molecular Biology Reports, vol.56, issue.2, pp.10-1007, 2009.
DOI : 10.1007/s11033-009-9851-5

. Invitrogen, A Manual of Methods for Expression of Recombinant Proteins in Pichia pastoris, Catalogue No, pp.195-215

U. K. Laemmli, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970.
DOI : 10.1038/227680a0

R. B. Belshe, M. H. Smith, C. B. Hall, R. Betts, and A. J. Hay, Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection, J. Virol, pp.62-1508, 1988.

I. A. Leneva, N. Roberts, E. A. Govorkova, O. G. Goloubeva, R. G. Webster et al., The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A, H9N2) influenza viruses, pp.48-101, 1074.
DOI : 10.1016/s0166-3542(00)00123-6

R. A. Black, P. A. Rota, N. Gorodkova, H. D. Klenk, and A. P. , Antibody response to the M2 protein of influenza A virus expressed in insect cells, Journal of General Virology, vol.74, issue.1, pp.74-143, 1993.
DOI : 10.1099/0022-1317-74-1-143

S. M. Ebrahimi and M. Tebianian, Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70359???610 in prokaryotic system as a fusion protein, Molecular Biology Reports, vol.48, issue.6, pp.10-1007, 2009.
DOI : 10.1007/s11033-009-9846-2

E. Hardy, E. Martínez, D. Diago, R. Díaz, D. González et al., Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris, Journal of Biotechnology, vol.77, issue.2-3, pp.77-157, 2000.
DOI : 10.1016/S0168-1656(99)00201-1

R. A. Lamb, C. J. Lai, and P. W. Choppin, Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins., Proc. Natl. Acad. Sci. USA, pp.4170-4174, 1981.
DOI : 10.1073/pnas.78.7.4170

S. L. Zebedee, C. D. Richardson, and R. A. Lamb, Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA, J. Virol, pp.56-502, 1985.